Progesterone

黄体酮

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameProgesterone
Drug Alias Name孕甾酮ProgesteronumProgesterona黄体素Utrogestan +[14] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionProgesterone receptor agonists
TargetsProgesterone receptor
Therapy Area/IndicationsLH deficiencyParturitionMenopausal symptoms +[45] 
Global Approved IndicationsPremenstrual SyndromeMenstruation DisturbancesAbortion, Threatened +[6] 
Approved Indications in ChinaPremenstrual SyndromeMenstruation DisturbancesAbortion, Threatened +[4] 
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[36] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesDaré Bioscience IncUtah State UniversityUniversity Of New Mexico Cancer Center +[19] 
Inactive CompaniesCanadian Institutes Of Health Research (Cihr)Productos Científicos S. A. De C. V.Obstetrix Medical Group +[30] 
Active IndicationsParturitionStress Disorders, Post-TraumaticSexual Abstinence +[21] 
Inactive IndicationsLH deficiencyMenopausal symptomsTobacco Use Disorder +[24] 

Other Information

ATC CodeG03DA04
Related LinksWikipediaDrugBankKEGG